Table 2. Modality of response/resistance to first-line VEGF/VEGFR inhibitors and possible second-line treatment options to be explored. Clinical response to first-line therapy Putative molecular ...
Most tumors release various signaling molecules to support their incessant growth, invasion, and metastasis. Some of these molecules, known as tumor angiogenic factors (TAF), are able to stimulate the ...
In recent years, interest has grown around two investigational peptides, BPC-157 and TB-500, proposed as part of a combined research-oriented protocol to explore tissue regeneration, angiogenesis, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback